Project information
COVID-19 Vaccines Safety Tracking in the Czech Republic
(CoVaST-CZ)
- Project Identification
- MUNI/IGA/1104/2021
- Project Period
- 1/2022 - 12/2022
- Investor / Pogramme / Project type
-
Masaryk University
- Internal grant agency MU
- MU Faculty or unit
- Faculty of Medicine
COVID-19 vaccines are the sole evidence-based intervention to control the ongoing pandemic, thus mandating substantial levels of public confidence in vaccines to accelerate the mass vaccination efforts. This project aims to provide independent post-marketing (phase IV) evidence on the short-term side effects of COVID-19 vaccines among the Czech population, focusing on booster doses, healthcare and pedagogical workers, and the young population.
Publications
Total number of publications: 14
2022
-
Prevalence and Drivers of COVID-19 Vaccine Booster Hesitancy Among German University Students and Employees
Frontiers in Public Health, year: 2022, volume: 10, edition: April 2022, DOI
-
Self-reported side effects of the Oxford AstraZeneca COVID-19 vaccine among healthcare workers in Ethiopia, Africa: A cross-sectional study
Frontiers in Public Health, year: 2022, volume: 10, edition: July 2022, DOI
-
Side Effects of COVID-19 Inactivated Virus vs. Adenoviral Vector Vaccines: Experience of Algerian Healthcare Workers
Frontiers in Public Health, year: 2022, volume: 10, edition: May 2022, DOI
-
Side Effects of COVID-19 Vaccines Primer Doses: Experience of Saudi Healthcare Workers Participating in CoVaST-SA
Vaccines, year: 2022, volume: 10, edition: 12, DOI